131 related articles for article (PubMed ID: 3915258)
1. Serum free C-peptide response to oral glucose loading as a parameter for the monitoring of pancreatic B-cell function in diabetic patients.
Hsieh SD; Kanazawa Y; Akanuma Y
Diabetes Res Clin Pract; 1985 Aug; 1(2):109-14. PubMed ID: 3915258
[TBL] [Abstract][Full Text] [Related]
2. Reduction of C-peptide secretion in noninsulin-dependent diabetic patients with long duration of insulin treatment.
Hsieh SD; Akanuma Y; Kawazu S; Mashiko S; Kanazawa Y; Iwamoto Y; Kikuchi M; Kosaka K
Endocrinol Jpn; 1983 Jun; 30(3):373-80. PubMed ID: 6363048
[TBL] [Abstract][Full Text] [Related]
3. A study of serum free C-peptide responses to oral glucose load in diabetic patients: with special reference to types of diabetes and methods of treatment.
Hsieh SD; Akanuma Y; Takaku F
Tohoku J Exp Med; 1984 Mar; 142(3):249-60. PubMed ID: 6374968
[TBL] [Abstract][Full Text] [Related]
4. Human plasma C-peptide immunoreactivity: its correlation with immunoreactive insulin in diabetes, and chronic liver and renal diseases.
Kajinuma H; Kanazawa Y; Sando H; Hayashi M; Kawazu S; Kosaka K
Endocrinol Jpn; 1979 Feb; 26(1):65-73. PubMed ID: 436802
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic B-cell function in non-insulin-dependent diabetes mellitus during successive periods of sulfonylurea and insulin treatment: serum C-peptide response to glucagon and urine C-peptide excretion.
Hsieh SD; Iwamoto Y; Matsuda A; Kuzuya T
Endocrinol Jpn; 1987 Aug; 34(4):561-7. PubMed ID: 3315640
[TBL] [Abstract][Full Text] [Related]
6. Circadian variations in plasma immunoreactive insulin (IRI) and C-peptide concentrations in adult onset (type II) diabetes mellitus.
Nicolau GY; Haus E; Lakatua DJ; Bogdan C; Petrescu E; Sackett-Lundeen L; Stelea S; Stelea P
Endocrinologie; 1984; 22(1):3-16. PubMed ID: 6369501
[TBL] [Abstract][Full Text] [Related]
7. Analysis of insulin secretion based on changes in plasma insulin and C-peptide in man.
Sakai T; Ohneda A; Nihei J; Kobayashi T
Tohoku J Exp Med; 1982 Dec; 138(4):427-40. PubMed ID: 6761899
[TBL] [Abstract][Full Text] [Related]
8. Clinical Utility of the Meal Tolerance Test in the Care of Patients with Type 2 Diabetes Mellitus.
Wakasaki H; Shono T; Nakao R; Yamamoto S; Minaga T; Fukuda S; Matsumoto R; Ohoshi T; Naka K; Nanjo K
Intern Med; 2020; 59(18):2229-2235. PubMed ID: 32938850
[TBL] [Abstract][Full Text] [Related]
9. Glucagon-glucose (GG) test for the estimation of the insulin reserve in diabetes.
Miki H; Matsuyama T; Fujii S; Komatsu R; Nishioeda Y; Omae T
Diabetes Res Clin Pract; 1992 Nov; 18(2):99-105. PubMed ID: 1478158
[TBL] [Abstract][Full Text] [Related]
10. The effect of 3-month ingestion of Ginkgo biloba extract (EGb 761) on pancreatic beta-cell function in response to glucose loading in individuals with non-insulin-dependent diabetes mellitus.
Kudolo GB
J Clin Pharmacol; 2001 Jun; 41(6):600-11. PubMed ID: 11402628
[TBL] [Abstract][Full Text] [Related]
11. C-peptide response to glucagon in type 2 diabetes mellitus: a comparison with oral glucose tolerance test.
Iwasaki Y; Kondo K; Hasegawa H; Oiso Y
Diabetes Res; 1994; 25(3):129-37. PubMed ID: 7671552
[TBL] [Abstract][Full Text] [Related]
12. Residual B-cell function in insulin dependent (Type 1) and non insulin-dependent (Type 2) diabetics (relationship between 24-hour C-peptide excretion and the clinical features of diabetes).
Gerö L; Korányi L; Tamás G
Diabete Metab; 1983 Sep; 9(3):183-7. PubMed ID: 6360742
[TBL] [Abstract][Full Text] [Related]
13. [Pancreatic polypeptide response to oral glucose load in patients with liver cirrhosis--interrelationship between PP and other pancreatic endocrine hormones].
Kawakami K
Nihon Naibunpi Gakkai Zasshi; 1988 Mar; 64(3):155-70. PubMed ID: 3294051
[TBL] [Abstract][Full Text] [Related]
14. Study of A- and B-cell function in beta-thalassemia major.
Maioli M; Pacifico A; Frulio T; Longinotti M
Acta Diabetol Lat; 1983; 20(2):143-52. PubMed ID: 6349202
[TBL] [Abstract][Full Text] [Related]
15. Correlation between minimal secretory capacity of pancreatic beta-cells and stability of diabetic control.
Fukuda M; Tanaka A; Tahara Y; Ikegami H; Yamamoto Y; Kumahara Y; Shima K
Diabetes; 1988 Jan; 37(1):81-8. PubMed ID: 3275557
[TBL] [Abstract][Full Text] [Related]
16. Progressive deterioration of beta-cell function in nonobese type 2 diabetic subjects. Postprandial plasma C-peptide level is an indication of insulin dependency.
Prando R; Odetti P; Melga P; Giusti R; Ciuchi E; Cheli V
Diabetes Metab; 1996 Jun; 22(3):185-91. PubMed ID: 8697306
[TBL] [Abstract][Full Text] [Related]
17. Secretory protein 7B2 response to oral glucose loading and intravenous glucagon injection in patients with diabetes mellitus.
Hisatomi A; Natori S; Iguchi H; Ohashi M; Umeda F; Nawata H
Fukuoka Igaku Zasshi; 1996 Dec; 87(12):266-73. PubMed ID: 9011109
[TBL] [Abstract][Full Text] [Related]
18. 3,5,3'-Triiodothyronine regulates insulin level in the circulation following glucose ingestion in humans.
Koh H; Fujii S; Nishioheda Y; Tsushima M; Nambu S
Arzneimittelforschung; 1986 Feb; 36(2):262-5. PubMed ID: 3516161
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of body weight, hyperinsulinemia and oral glucose load on serum C-peptide/insulin molar ratio.
Okada N; Kobayashi M; Ohtsuka H; Shigematsu S; Nagasawa Y; Komatsu M; Aizawa T; Yamada T
Horm Metab Res; 1992 Sep; 24(9):429-33. PubMed ID: 1427614
[TBL] [Abstract][Full Text] [Related]
20. Correlation of serum CPR to plasma glucose ratio with various indices of insulin secretion and diseases duration in type 2 diabetes.
Okuno Y; Sakaguchi K; Komada H; Hashimoto N; Hirota Y; Nakamura T; Ogawa W; Seino S
Kobe J Med Sci; 2013 Apr; 59(2):E44-53. PubMed ID: 23756662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
